Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
17
ZKH Quote, Financials, Valuation and Earnings
Last price:
$3.19
Seasonality move
:
-2.38%
Day range:
$3.10 - $3.20
52-week range:
$2.50 - $4.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.25x
P/B ratio:
1.20x
Volume:
21.1K
Avg. volume:
31K
1-year change:
-11.84%
Market cap:
$500.3M
Revenue:
$1.2B
EPS (TTM):
-$0.19
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $679.1M | $1.2B | $1.2B | $1.2B | $1.2B | |
| Revenue Growth (YoY) | -- | 74.58% | 4.42% | -0.41% | -0.97% | |
| Cost of Revenues | $580.5M | $1B | $1B | $1B | $1B | |
| Gross Profit | $98.6M | $161M | $196.2M | $205.3M | $210.5M | |
| Gross Profit Margin | 14.52% | 13.58% | 15.85% | 16.65% | 17.24% | |
| R&D Expenses | $21.7M | $39.7M | $35.8M | $24.9M | $23.6M | |
| Selling, General & Admin | $100.5M | $224.5M | $192.9M | $174.8M | $179.5M | |
| Other Inc / (Exp) | -$1.1M | -$179K | $5M | $8.4M | $3.7M | |
| Operating Expenses | $155M | $333M | $298.3M | $261.7M | $257.7M | |
| Operating Income | -$56.4M | -$172M | -$102.1M | -$56.4M | -$47.2M | |
| Net Interest Expenses | -- | -- | $11.9M | -- | -- | |
| EBT. Incl. Unusual Items | -$57.3M | -$169.4M | -$108.9M | -$43.1M | -$37.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $277.4K | $31K | -$70.1K | $27.6K | $141.2K | |
| Net Income to Company | -$57.5M | -$169.5M | -$108.8M | -$43.1M | -$37.4M | |
| Minority Interest in Earnings | -$664.1K | -$4.4M | -$678.9K | $82.8K | -- | |
| Net Income to Common Excl Extra Items | -$58.2M | -$173.8M | -$109.5M | -$43M | -$37.4M | |
| Basic EPS (Cont. Ops) | -$0.53 | -$1.40 | -$1.15 | -$3.12 | -$0.24 | |
| Diluted EPS (Cont. Ops) | -$0.53 | -$1.40 | -$1.15 | -$3.12 | -$0.24 | |
| Weighted Average Basic Share | $160.6M | $160.6M | $160.6M | $43.7M | $163.9M | |
| Weighted Average Diluted Share | $160.6M | $160.6M | $160.6M | $43.7M | $163.9M | |
| EBITDA | -$51.3M | -$159.6M | -$83.6M | -$30M | -$26.9M | |
| EBIT | -$56.7M | -$167.8M | -$94.9M | -$40.3M | -$34.6M | |
| Revenue (Reported) | $679.1M | $1.2B | $1.2B | $1.2B | $1.2B | |
| Operating Income (Reported) | -$56.4M | -$172M | -$102.1M | -$56.4M | -$47.2M | |
| Operating Income (Adjusted) | -$56.7M | -$167.8M | -$94.9M | -$40.3M | -$34.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $283.3M | $260M | $266M | |
| Revenue Growth (YoY) | -- | -- | -- | -8.21% | 2.32% | |
| Cost of Revenues | -- | -- | $234.9M | $213.3M | $220.4M | |
| Gross Profit | -- | -- | $48.3M | $46.7M | $45.7M | |
| Gross Profit Margin | -- | -- | 17.06% | 17.96% | 17.16% | |
| R&D Expenses | -- | -- | $7M | $5.6M | $5.4M | |
| Selling, General & Admin | -- | -- | $46.7M | $45.6M | $38.5M | |
| Other Inc / (Exp) | -- | -- | $6M | $3.7M | $468.5K | |
| Operating Expenses | -- | -- | $69.9M | $64.8M | $56.8M | |
| Operating Income | -- | -- | -$21.5M | -$18.1M | -$11.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$14.3M | -$12.7M | -$9.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $19.3K | $12.3K | $34K | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -$12.4K | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$14.3M | -$12.7M | -$9.2M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.14 | -$0.10 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.14 | -$0.10 | -$0.05 | |
| Weighted Average Basic Share | -- | -- | $160.6M | $163.7M | $162.7M | |
| Weighted Average Diluted Share | -- | -- | $160.6M | $163.7M | $162.7M | |
| EBITDA | -- | -- | -$13.8M | -$11.9M | -$8.8M | |
| EBIT | -- | -- | -$13.8M | -$11.9M | -$8.8M | |
| Revenue (Reported) | -- | -- | $283.3M | $260M | $266M | |
| Operating Income (Reported) | -- | -- | -$21.5M | -$18.1M | -$11.1M | |
| Operating Income (Adjusted) | -- | -- | -$13.8M | -$11.9M | -$8.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $1.2B | $2.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $1B | $1.7B | |
| Gross Profit | -- | -- | -- | $203.5M | $355.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $23.5M | $40.3M | |
| Selling, General & Admin | -- | -- | -- | $173.9M | $302.7M | |
| Other Inc / (Exp) | -- | -- | $9.8M | $6.2M | $5M | |
| Operating Expenses | -- | -- | -- | $256.9M | $436.1M | |
| Operating Income | -- | -- | -- | -$53.4M | -$80.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$41.9M | -$65.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $21.2K | $254.8K | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -$453.3K | $92.9K | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$41.8M | -$65.4M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.90 | -$0.19 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.90 | -$0.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -$36.5M | -$60.9M | |
| EBIT | -- | -- | -- | -$38.8M | -$60.9M | |
| Revenue (Reported) | -- | -- | -- | $1.2B | $2.1B | |
| Operating Income (Reported) | -- | -- | -- | -$53.4M | -$80.7M | |
| Operating Income (Adjusted) | -- | -- | -- | -$38.8M | -$60.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $283.3M | $260M | $266M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $234.9M | $213.3M | $220.4M | |
| Gross Profit | -- | -- | $48.3M | $46.7M | $45.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $7M | $5.6M | $5.4M | |
| Selling, General & Admin | -- | -- | $46.7M | $45.6M | $38.5M | |
| Other Inc / (Exp) | -- | -- | $6M | $3.7M | $468.5K | |
| Operating Expenses | -- | -- | $69.9M | $64.8M | $56.8M | |
| Operating Income | -- | -- | -$21.5M | -$18.1M | -$11.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$14.3M | -$12.7M | -$9.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $19.3K | $12.3K | $34K | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -$12.4K | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$14.3M | -$12.7M | -$9.2M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.14 | -$0.10 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.14 | -$0.10 | -$0.05 | |
| Weighted Average Basic Share | -- | -- | $160.6M | $163.7M | $162.7M | |
| Weighted Average Diluted Share | -- | -- | $160.6M | $163.7M | $162.7M | |
| EBITDA | -- | -- | -$13.8M | -$11.9M | -$8.8M | |
| EBIT | -- | -- | -$13.8M | -$11.9M | -$8.8M | |
| Revenue (Reported) | -- | -- | $283.3M | $260M | $266M | |
| Operating Income (Reported) | -- | -- | -$21.5M | -$18.1M | -$11.1M | |
| Operating Income (Adjusted) | -- | -- | -$13.8M | -$11.9M | -$8.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $84.4M | $283.3M | $153.9M | $195.1M | |
| Short Term Investments | -- | -- | -- | $123.3M | $74.5M | |
| Accounts Receivable, Net | -- | $433.3M | $444.5M | $513.5M | $423.3M | |
| Inventory | -- | $119.7M | $95.1M | $94.4M | $85.7M | |
| Prepaid Expenses | -- | $23.4M | $15.8M | $16.7M | $17.5M | |
| Other Current Assets | -- | $12.7M | $19.5M | $5.1M | $3M | |
| Total Current Assets | -- | $828.1M | $910.7M | $981.1M | $848M | |
| Property Plant And Equipment | -- | $95.7M | $67.4M | $52.2M | $49.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $4.8M | $4.5M | $4.3M | $4.2M | |
| Other Intangibles | -- | $3.3M | $5.1M | $4.4M | $3.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $931.9M | $987.6M | $1B | $905.6M | |
| Accounts Payable | -- | $307.3M | $370.4M | $405.6M | $348.8M | |
| Accrued Expenses | -- | -- | -- | -- | $50M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $136.6K | |
| Current Portion Of Capital Lease Obligations | -- | $20.5M | $13.9M | $12.9M | $11.1M | |
| Other Current Liabilities | -- | $21.9M | $22M | $27.1M | $18.3M | |
| Total Current Liabilities | -- | $531.9M | $504.7M | $568.2M | $457.5M | |
| Long-Term Debt | -- | -- | -- | -- | $5.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $1.4B | $1.6B | $589M | $481.2M | |
| Common Stock | -- | $160 | $150 | $560 | $550 | |
| Other Common Equity Adj | -- | $682.1K | -$6.8M | -$2.7M | $1.5M | |
| Common Equity | -- | -$434.6M | -$590M | $453M | $424.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $612.6K | $614.3K | -- | -- | |
| Total Equity | -- | -$433.9M | -$589.4M | $453M | $424.4M | |
| Total Liabilities and Equity | -- | $931.9M | $987.6M | $1B | $905.6M | |
| Cash and Short Terms | -- | $84.4M | $283.3M | $277.2M | $269.6M | |
| Total Debt | -- | $117.9M | $37.8M | $83.7M | $49.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $153.9M | $156.4M | |
| Short Term Investments | -- | -- | -- | $111M | $75.4M | |
| Accounts Receivable, Net | -- | -- | -- | $448.5M | $386.7M | |
| Inventory | -- | -- | -- | $95.8M | $99.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | $23.9M | $24.4M | |
| Total Current Assets | -- | -- | -- | $915.6M | $788.5M | |
| Property Plant And Equipment | -- | -- | -- | $50.4M | $46.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $4.3M | $4.2M | |
| Other Intangibles | -- | -- | -- | $4.1M | $3.4M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | $974.4M | $842.8M | |
| Accounts Payable | -- | -- | -- | $330.8M | $318.2M | |
| Accrued Expenses | -- | -- | -- | $58.9M | $48.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $98.5M | $22.3M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $11.7M | $9.5M | |
| Other Current Liabilities | -- | -- | -- | -- | $65.5K | |
| Total Current Liabilities | -- | -- | -- | $503.9M | $401.9M | |
| Long-Term Debt | -- | -- | -- | -- | $6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $522.2M | $424.7M | |
| Common Stock | -- | -- | -- | $560 | $550 | |
| Other Common Equity Adj | -- | -- | -- | -$2.2M | $1.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $452.2M | $418.1M | |
| Total Liabilities and Equity | -- | -- | -- | $974.4M | $842.8M | |
| Cash and Short Terms | -- | -- | -- | $264.9M | $231.8M | |
| Total Debt | -- | -- | -- | $98.5M | $28.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$57.5M | -$169.5M | -$108.8M | -$43.1M | -$37.4M | |
| Depreciation & Amoritzation | $5.4M | $8.2M | $11.3M | $10.4M | $7.6M | |
| Stock-Based Compensation | $13.3M | $28.4M | $4.7M | $2.5M | $15.1M | |
| Change in Accounts Receivable | -$111.6M | -$190.6M | -$36.8M | -$88.7M | $86.6M | |
| Change in Inventories | -$9.6M | -$51M | $12.8M | -$7.5M | $2.5M | |
| Cash From Operations | $4.6M | -$214.2M | -$75.1M | -$80.3M | $31.9M | |
| Capital Expenditures | $9.1M | $24.5M | $7.5M | $7.9M | $11.6M | |
| Cash Acquisitions | -$5.7M | -$1.6M | -- | -- | -- | |
| Cash From Investing | -$8.4M | -$14.6M | -$5.5M | -$128.4M | $38.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $18.6M | $62.6M | $319.8M | $157.5M | $130.6M | |
| Long-Term Debt Repaid | -$15.4M | -$33.4M | -$120.2M | -$110.1M | -$163.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$5.7M | |
| Other Financing Activities | $289.8K | -$2.1M | -$5.7M | -$713.1K | $2.8M | |
| Cash From Financing | $264.7M | $27M | $193.9M | $101.2M | -$35.4M | |
| Beginning Cash (CF) | $93.5M | $377.6M | $167.8M | $283.6M | $174.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $260.9M | -$201.7M | $113.4M | -$107.5M | $35M | |
| Ending Cash (CF) | $353.3M | $174.5M | $298.6M | $176.8M | $211.4M | |
| Levered Free Cash Flow | -$4.5M | -$238.6M | -$82.5M | -$88.1M | $20.4M | |
| Period Ending | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$94.5M | -$44.9M | |
| Depreciation & Amoritzation | -- | -- | -- | $8.3M | $7.9M | |
| Stock-Based Compensation | -- | -- | -- | $4.8M | $1.4M | |
| Change in Accounts Receivable | -- | -- | -- | -$51.4M | -$63.6M | |
| Change in Inventories | -- | -- | -- | $14.4M | -$9.6M | |
| Cash From Operations | -- | -- | -- | -$78.3M | -$70.3M | |
| Capital Expenditures | -- | -- | -- | -- | $4.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$4.9M | -$88.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $311.4M | $95.9M | |
| Long-Term Debt Repaid | -- | -- | -- | -$83.7M | -$70.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$3.3M | -$3.2M | |
| Cash From Financing | -- | -- | -- | $224.4M | $22.3M | |
| Beginning Cash (CF) | -- | -- | -- | $164.5M | $277.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $22.6M | $3.7M | |
| Additions / Reductions | -- | -- | -- | $141.2M | -$136.2M | |
| Ending Cash (CF) | -- | -- | -- | $328.4M | $144.7M | |
| Levered Free Cash Flow | -- | -- | -- | -- | -$74.7M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | $1.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | $4.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get ZKH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ZKH
Sector
P/E ratio
--
18.58x
PEG ratio
--
0.25x
P/B ratio
1.20x
1.75x
Price / LTM sales
0.25x
0.94x
Growth Metrics
ZKH
Sector
Revenue growth
2.32%
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
--
4.35%
Earnings forecast
-$0.03
$0.40
Profitability
ZKH
Sector
Profitability FY 2024
$210.5M
$393.9M
Return on invested capital
-13.04%
5.32%
Return on assets
-7.04%
3.49%
Return on equity
-15.05%
8.55%
Earnings Date
Last Earnings Date
May
20
Next Earnings Date
Aug
22
Estimated Next Earnings Date
Aug
19
Balance Sheet
ZKH
Sector
Total cash
$231.8M
$154.3M
Short term investments
$74.5M
$35.5M
Total assets
$905.6M
$1.7B
Long term debt
$28.3M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
